NYSE:CCAC

CITIC Capital Acquisition Competitors

$10.06
-0.05 (-0.49 %)
(As of 04/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.00
Now: $10.06
$10.07
50-Day Range
$9.96
MA: $10.31
$11.40
52-Week Range
$9.51
Now: $10.06
$12.20
Volume601,337 shs
Average Volume686,021 shs
Market Capitalization$277.66 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

CITIC Capital Acquisition (NYSE:CCAC) Vs. AJAX, AJAX, BTWN, CMLF, BOAC, and BOWX

Should you be buying CCAC stock or one of its competitors? Companies in the industry of "shell companies" are considered alternatives and competitors to CITIC Capital Acquisition, including Ajax I (AJAX), Ajax I (AJAX), Bridgetown (BTWN), CM Life Sciences (CMLF), Bluescape Opportunities Acquisition (BOAC), and BowX Acquisition (BOWX).

Ajax I (NYSE:AJAX) and CITIC Capital Acquisition (NYSE:CCAC) are both small-cap unclassified companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

Profitability

This table compares Ajax I and CITIC Capital Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/A

Earnings and Valuation

This table compares Ajax I and CITIC Capital Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Ajax I and CITIC Capital Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
CITIC Capital Acquisition0000N/A

Insider and Institutional Ownership

68.2% of CITIC Capital Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

CITIC Capital Acquisition beats Ajax I on 1 of the 1 factors compared between the two stocks.

Ajax I (NYSE:AJAX) and CITIC Capital Acquisition (NYSE:CCAC) are both small-cap unclassified companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations.

Insider & Institutional Ownership

68.2% of CITIC Capital Acquisition shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and price targets for Ajax I and CITIC Capital Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Ajax I0000N/A
CITIC Capital Acquisition0000N/A

Profitability

This table compares Ajax I and CITIC Capital Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Ajax IN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/A

Valuation and Earnings

This table compares Ajax I and CITIC Capital Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ajax IN/AN/AN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/AN/AN/A

Summary

CITIC Capital Acquisition beats Ajax I on 1 of the 1 factors compared between the two stocks.

Bridgetown (NASDAQ:BTWN) and CITIC Capital Acquisition (NYSE:CCAC) are both small-cap unclassified companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, analyst recommendations and risk.

Valuation and Earnings

This table compares Bridgetown and CITIC Capital Acquisition's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BridgetownN/AN/AN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/AN/AN/A

Institutional and Insider Ownership

68.2% of CITIC Capital Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Bridgetown and CITIC Capital Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Bridgetown0000N/A
CITIC Capital Acquisition0000N/A

Profitability

This table compares Bridgetown and CITIC Capital Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BridgetownN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/A

Summary

CITIC Capital Acquisition beats Bridgetown on 1 of the 1 factors compared between the two stocks.

CM Life Sciences (NASDAQ:CMLF) and CITIC Capital Acquisition (NYSE:CCAC) are both small-cap financial services companies, but which is the superior stock? We will contrast the two companies based on the strength of their dividends, earnings, valuation, risk, profitability, institutional ownership and analyst recommendations.

Institutional & Insider Ownership

68.2% of CITIC Capital Acquisition shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares CM Life Sciences and CITIC Capital Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CM Life SciencesN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for CM Life Sciences and CITIC Capital Acquisition, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CM Life Sciences0000N/A
CITIC Capital Acquisition0000N/A

Earnings & Valuation

This table compares CM Life Sciences and CITIC Capital Acquisition's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CM Life SciencesN/AN/AN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/AN/AN/A

Summary

CITIC Capital Acquisition beats CM Life Sciences on 1 of the 1 factors compared between the two stocks.

CITIC Capital Acquisition (NYSE:CCAC) and Bluescape Opportunities Acquisition (NYSE:BOAC) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, earnings, valuation and risk.

Valuation & Earnings

This table compares CITIC Capital Acquisition and Bluescape Opportunities Acquisition's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CITIC Capital AcquisitionN/AN/AN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/AN/AN/A

Analyst Recommendations

This is a summary of current ratings for CITIC Capital Acquisition and Bluescape Opportunities Acquisition, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
CITIC Capital Acquisition0000N/A
Bluescape Opportunities Acquisition0000N/A

Insider and Institutional Ownership

68.2% of CITIC Capital Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares CITIC Capital Acquisition and Bluescape Opportunities Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
CITIC Capital AcquisitionN/AN/AN/A
Bluescape Opportunities AcquisitionN/AN/AN/A

Summary

CITIC Capital Acquisition beats Bluescape Opportunities Acquisition on 1 of the 1 factors compared between the two stocks.

BowX Acquisition (NASDAQ:BOWX) and CITIC Capital Acquisition (NYSE:CCAC) are both small-cap unclassified companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability and earnings.

Valuation and Earnings

This table compares BowX Acquisition and CITIC Capital Acquisition's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BowX AcquisitionN/AN/AN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/AN/AN/A

Institutional & Insider Ownership

68.2% of CITIC Capital Acquisition shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current recommendations for BowX Acquisition and CITIC Capital Acquisition, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
BowX Acquisition0000N/A
CITIC Capital Acquisition0000N/A

Profitability

This table compares BowX Acquisition and CITIC Capital Acquisition's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
BowX AcquisitionN/AN/AN/A
CITIC Capital AcquisitionN/AN/AN/A

Summary

CITIC Capital Acquisition beats BowX Acquisition on 1 of the 1 factors compared between the two stocks.


CITIC Capital Acquisition Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
Ajax I logo
AJAX
Ajax I
0.0$10.11-0.3%$904.27 millionN/A0.00Increase in Short Interest
BTWN
Bridgetown
0.0$10.68-1.3%$794.31 millionN/A0.00
CMLF
CM Life Sciences
0.0$13.98-2.8%$773.71 millionN/A0.00
BOAC
Bluescape Opportunities Acquisition
0.0$10.11-0.9%$767.73 millionN/A0.00Decrease in Short Interest
BOWX
BowX Acquisition
0.0$12.45-8.8%$751.67 millionN/A0.00Increase in Short Interest
VYGG
Vy Global Growth
0.0$10.38-0.4%$746.06 millionN/A0.00
TPGY
TPG Pace Beneficial Finance
0.3$16.06-5.5%$702.63 millionN/A0.00
HZON
Horizon Acquisition Co. II
0.0$10.22-0.9%$677.53 millionN/A0.00
LCY
Landcadia Holdings III
1.7$10.42-0.2%$670.79 millionN/A0.00News Coverage
ACIC
Atlas Crest Investment
0.0$10.01-0.5%$625.63 millionN/A0.00
MIT
Mason Industrial Technology
0.0$9.85-0.2%$615.63 millionN/A0.00News Coverage
VSPR
Vesper Healthcare Acquisition
1.7$10.55-0.8%$606.63 millionN/A0.00Analyst Report
Decrease in Short Interest
HAAC
Health Assurance Acquisition
0.0$10.67-1.4%$590.85 millionN/A0.00
KVSC
Khosla Ventures Acquisition Co. III
0.0$10.15-0.0%$571.16 millionN/A0.00
VAQC
Vector Acquisition Corp II
0.0$10.00-0.5%$570.63 millionN/A0.00Quiet Period Expiration
TPG Pace Tech Opportunities logo
PACE
TPG Pace Tech Opportunities
0.0$10.05-0.0%$565.31 millionN/A0.00
CFII
CF Finance Acquisition Corp. II
0.3$8.39-2.5%$533.60 millionN/A0.00Increase in Short Interest
News Coverage
MUDS
Mudrick Capital Acquisition Co. II
0.0$13.24-0.9%$523.39 millionN/A0.00High Trading Volume
Unusual Options Activity
MAAC
Montes Archimedes Acquisition
0.0$9.92-0.7%$521.51 millionN/A0.00
SNRH
Senior Connect Acquisition Corp. I
0.0$9.86-0.7%$513.88 millionN/A0.00News Coverage
MOTV
Motive Capital
0.0$9.92-0.6%$513.36 millionN/A0.00
DGNU
ArcLight Clean Transition Corp. II Unit
0.0$10.20-0.4%$510 millionN/A0.00
CTAQ
Carney Technology Acquisition Corp. II
0.0$9.90-0.6%$507.01 millionN/A0.00
IIAC
Investindustrial Acquisition
0.0$9.99-0.3%$502.63 millionN/A0.00
SPNV
Supernova Partners Acquisition
0.0$9.99-0.2%$502.63 millionN/A0.00Increase in Short Interest
EPHY
Epiphany Technology Acquisition
0.0$9.83-0.6%$502.43 millionN/A0.00
GMII
Gores Metropoulos II
0.0$10.01-0.3%$500.50 millionN/A0.00
AGCB
Altimeter Growth Corp. 2
0.0$11.03-0.2%$496.35 millionN/A0.00News Coverage
KVSB
Khosla Ventures Acquisition Co. II
0.0$10.24-0.4%$470.22 millionN/A0.00
NGAC
NextGen Acquisition
0.0$10.00-0.1%$468.75 millionN/A0.00Increase in Short Interest
News Coverage
SPFR
Jaws Spitfire Acquisition
0.0$10.69-0.1%$461.01 millionN/A0.00
HIGA
H.I.G. Acquisition
0.0$9.98-0.2%$456.47 millionN/A0.00Decrease in Short Interest
GHVI
Gores Holdings VI
0.0$12.96-0.5%$447.12 millionN/A0.00News Coverage
LUXA
Lux Health Tech Acquisition
0.0$10.31-0.8%$444.62 millionN/A0.00Decrease in Short Interest
FSRV
FinServ Acquisition
0.0$13.67-1.3%$436.28 millionN/A0.00
CAP
Capitol Investment Corp. V
0.0$9.98-0.6%$430.39 millionN/A0.00
RMGB
RMG Acquisition Co. II
0.0$9.97-0.0%$429.96 millionN/A0.00News Coverage
GFX
Golden Falcon Acquisition
0.0$9.89-0.6%$426.51 millionN/A0.00
PCPC
Periphas Capital Partnering
0.0$24.68-0.7%$414.69 millionN/A0.00
PIAI
Prime Impact Acquisition I
0.0$9.92-0.2%$401.87 millionN/A0.00Decrease in Short Interest
News Coverage
NSTB
Northern Star Investment Corp. II
0.0$9.98-0.3%$399.20 millionN/A0.00
HOL
Holicity
0.0$10.57-3.1%$396.38 millionN/A0.00Increase in Short Interest
News Coverage
RAAC
Revolution Acceleration Acquisition
0.0$10.20-0.1%$391.00 millionN/A0.00
TSIA
TS Innovation Acquisitions
0.0$10.30-1.4%$386.25 millionN/A0.00Increase in Short Interest
XPOA
DPCM Capital
0.0$9.98-0.3%$385.48 millionN/A0.00Increase in Short Interest
KVSA
Khosla Ventures Acquisition
0.0$10.57-0.2%$379.46 millionN/A0.00Quiet Period Expiration
IGAC
IG Acquisition
0.0$10.00-0.4%$375 millionN/A0.00Decrease in Short Interest
PRSR
Prospector Capital
0.0$9.87-0.2%$370.13 millionN/A0.00
GMBT
Queen's Gambit Growth Capital
0.0$9.85-0.0%$369.38 millionN/A0.00
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.